insights_auto
Why is 0QF down ၂.၆၅%?
Dive Deeperchevron_right
0QF:ETR
Moderna Inc
၁၉၂.၀၄ €
arrow_downward
-၂.၆၅%(-၅.၂၂) 1D
အောက် ၁၃, GMT+၂ ၀၉:၂၉:၀၃ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
၁၉၀.၁၀ €
High
၁၉၂.၀၄ €
Low
၁၉၀.၁၀ €
Mkt. cap
ဋေ ၈.၅၃ ထ
Avg. vol.
၂.၈၃ သောင်း
Volume
၃.၇၃ ထောင်
52-wk high
၁၉၃.၅၈ €
52-wk low
၁၉.၃၇ €
No. of employees
၅ ထောင်
Open
၁၉၀.၁၀ €
High
၁၉၂.၀၄ €
Low
၁၉၀.၁၀ €
Mkt. cap
ဋေ ၈.၅၃ ထ
Avg. vol.
၂.၈၃ သောင်း
Volume
၃.၇၃ ထောင်
52-wk high
၁၉၃.၅၈ €
52-wk low
၁၉.၃၇ €
No. of employees
၅ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၄၅ မိနစ်
Moderna's Stock Swings Are Loud — Its Science Speaks on October 24
TIKR.com
·
ပြီးခဲ့သည့် ၅ နာရီ
Moderna Stock Soared 14% as NIH Plans COVID-Style Push for Cancer Vaccines
Simply Wall Street
·
ပြီးခဲ့သည့် ၇ နာရီ
Moderna Stock Puts MRNA Cancer Vaccine Shares Back In Focus
Investing.com
·
ပြီးခဲ့သည့် ၈ နာရီ
Moderna technical outlook: bullish trend meets near-term pullback
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc